DrugMay 31, 2017
DEXTROSE Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use recall — FDA D-0862-2017
Presence of Particulate Matter: human hair found within an internal sample syringe.
Class IFDA: OngoingHospira Inc.
Recall history in this database
Classification mix: Class III: 1, Class I: 1.
DrugDec 14, 2016
Hospira 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count recall — FDA D-0169-2017
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Class IIIFDA: TerminatedHospira Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Hospira Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.